Related Experiment Video

Updated: Aug 11, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Potential role of CCR5 polymorphism in the development of AIDS dementia complex

L A Boven1, T van der Bruggen, B S van Asbeck

  • 1Eijkman-Winkler Institute for Microbiology, Infectious Diseases and Inflammation, section NeuroImmunology, AZU, room G04.614, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. l.a.boven@lab.azu.nl

FEMS Immunology and Medical Microbiology
|November 27, 1999
PubMed

Insights

The CCR5 gene variant (DeltaCCR5) confers resistance to HIV-1 infection and influences AIDS dementia complex onset. Understanding CCR5 genotypes is crucial for interpreting HIV research and disease mechanisms.

Area of Science:

  • Immunology
  • Virology
  • Genetics

Background:

  • Chemokine receptors like CCR5 are essential for HIV-1 entry into macrophages.
  • A specific CCR5 allele defect (DeltaCCR5) provides significant resistance to HIV-1 infection.

Purpose of the Study:

  • To highlight the significance of the DeltaCCR5 allele in both in vitro and in vivo HIV-1 research.
  • To investigate the impact of CCR5 polymorphism on AIDS dementia complex and HIV-1 replication.

Main Methods:

  • Analysis of CCR5 polymorphism in relation to HIV-1 infection.
  • In vitro studies assessing HIV-1 replication.
  • In vivo studies examining AIDS dementia complex onset.

Main Results:

  • DeltaCCR5 genotype is linked to resistance to HIV-1 infection.
  • CCR5 polymorphism may influence the onset of AIDS dementia complex.
  • HIV-1 replication is affected by the DeltaCCR5 allele in vitro.

Conclusions:

  • The DeltaCCR5 allele plays a critical role in modulating HIV-1 infection and disease progression.
  • Knowledge of an individual's CCR5 genotype aids in interpreting research findings.
  • CCR5 genotyping may reveal new insights into HIV-1 pathogenesis and disease mechanisms.

More Related Videos

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

A Rat Model of EcoHIV Brain Infection08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...